Literature DB >> 27591113

Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.

Olivia A Skrobot1, Johannes Attems2, Margaret Esiri3, Tibor Hortobágyi4,5, James W Ironside6, Rajesh N Kalaria2, Andrew King7, George A Lammie8, David Mann9, James Neal10, Yoav Ben-Shlomo10, Patrick G Kehoe1, Seth Love1.   

Abstract

There are no generally accepted protocols for post-mortem assessment in cases of suspected vascular cognitive impairment. Neuropathologists from seven UK centres have collaborated in the development of a set of vascular cognitive impairment neuropathology guidelines (VCING), representing a validated consensus approach to the post-mortem assessment and scoring of cerebrovascular disease in relation to vascular cognitive impairment. The development had three stages: (i) agreement on a sampling protocol and scoring criteria, through a series of Delphi method surveys; (ii) determination of inter-rater reliability for each type of pathology in each region sampled (Gwet's AC2 coefficient); and (iii) empirical testing and validation of the criteria, by blinded post-mortem assessment of brain tissue from 113 individuals (55 to 100 years) without significant neurodegenerative disease who had had formal cognitive assessments within 12 months of death. Fourteen different vessel and parenchymal pathologies were assessed in 13 brain regions. Almost perfect agreement (AC2 > 0.8) was found when the agreed criteria were used for assessment of leptomeningeal, cortical and capillary cerebral amyloid angiopathy, large infarcts, lacunar infarcts, microhaemorrhage, larger haemorrhage, fibrinoid necrosis, microaneurysms, perivascular space dilation, perivascular haemosiderin leakage, and myelin loss. There was more variability (but still reasonably good agreement) in assessment of the severity of arteriolosclerosis (0.45-0.91) and microinfarcts (0.52-0.84). Regression analyses were undertaken to identify the best predictors of cognitive impairment. Seven pathologies-leptomeningeal cerebral amyloid angiopathy, large infarcts, lacunar infarcts, microinfarcts, arteriolosclerosis, perivascular space dilation and myelin loss-predicted cognitive impairment. Multivariable logistic regression determined the best predictive models of cognitive impairment. The preferred model included moderate/severe occipital leptomeningeal cerebral amyloid angiopathy, moderate/severe arteriolosclerosis in occipital white matter, and at least one large infarct (area under the receiver operating characteristic curve 77%). The presence of 0, 1, 2 or 3 of these features resulted in predicted probabilities of vascular cognitive impairment of 16%, 43%, 73% or 95%, respectively. We have developed VCING criteria that are reproducible and clinically predictive. Assuming our model can be validated in an independent dataset, we believe that this will be helpful for neuropathologists in reporting a low, intermediate or high likelihood that cerebrovascular disease contributed to cognitive impairment.10.1093/brain/aww214_video_abstractaww214_video_abstract.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cerebrovascular disease; neuropathology; vascular cognitive impairment; vascular dementia

Mesh:

Substances:

Year:  2016        PMID: 27591113     DOI: 10.1093/brain/aww214

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  64 in total

1.  Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline.

Authors:  Patricia A Boyle; Jingyun Yang; Lei Yu; Sue E Leurgans; Ana W Capuano; Julie A Schneider; Robert S Wilson; David A Bennett
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

2.  Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients.

Authors:  Dejan Jakimovski; Ralph Hb Benedict; Karen Marr; Sirin Gandhi; Niels Bergsland; Bianca Weinstock-Guttman; Robert Zivadinov
Journal:  Mult Scler       Date:  2019-01-09       Impact factor: 6.312

3.  Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease.

Authors:  James A R Nicoll; George R Buckland; Charlotte H Harrison; Anton Page; Scott Harris; Seth Love; James W Neal; Clive Holmes; Delphine Boche
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

Review 4.  Emerging concepts in sporadic cerebral amyloid angiopathy.

Authors:  Andreas Charidimou; Gregoire Boulouis; M Edip Gurol; Cenk Ayata; Brian J Bacskai; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

5.  Brains for Dementia Research: The Importance of Cohorts in Brain Banking.

Authors:  Paul T Francis; Gillian M Hayes; Helen Costello; David R Whitfield
Journal:  Neurosci Bull       Date:  2019-01-02       Impact factor: 5.203

6.  The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses.

Authors:  Lilah M Besser; Walter A Kukull; Merilee A Teylan; Eileen H Bigio; Nigel J Cairns; Julia K Kofler; Thomas J Montine; Julie A Schneider; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2018-08-01       Impact factor: 3.685

7.  Association of amyloid angiopathy with microbleeds in logopenic progressive aphasia: an imaging-pathology study.

Authors:  M Buciuc; J R Duffy; M M Machulda; A J Spychalla; J L Gunter; C R Jack; C Giannini; A Raghunathan; D W Dickson; K A Josephs; J L Whitwell
Journal:  Eur J Neurol       Date:  2020-11-12       Impact factor: 6.089

8.  Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice.

Authors:  Rajnish Bharadwaj; Patrick J Cimino; Margaret E Flanagan; Caitlin S Latimer; Luis F Gonzalez-Cuyar; Gordana Juric-Sekhar; Thomas J Montine; Desiree A Marshall; C Dirk Keene
Journal:  Histopathology       Date:  2017-11-22       Impact factor: 5.087

9.  Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.

Authors:  Keith A Josephs; Peter R Martin; Stephen D Weigand; Nirubol Tosakulwong; Marina Buciuc; Melissa E Murray; Leonard Petrucelli; Matthew L Senjem; Anthony J Spychalla; David S Knopman; Bradley F Boeve; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Clifford R Jack; Jennifer L Whitwell
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

Review 10.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.